blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3604303

EP3604303 - NOVEL PYRROLOPYRIDINE DERIVATIVE, METHOD FOR PRODUCING SAME, AND USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.11.2023
Database last updated on 19.10.2024
FormerThe patent has been granted
Status updated on  16.12.2022
FormerGrant of patent is intended
Status updated on  11.08.2022
FormerRequest for examination was made
Status updated on  03.01.2020
FormerThe international publication has been made
Status updated on  29.09.2018
Most recent event   Tooltip09.02.2024Lapse of the patent in a contracting state
New state(s): SI		published on 13.03.2024  [2024/11]
Applicant(s)For all designated states
ST Pharm Co., Ltd.
231, Hyeomnyeok-ro
Siheung-si, Gyeonggi-do 15086 / KR
[2020/06]
Inventor(s)01 / KIM, Bong Jin
407-2202 Horyuewool maeul
4 Dang-ji
469 Namsaejong-ro
Saejong-si, 30150 / KR
02 / LEE, Ill Young
202-202
343 Jijok-ro
Yuseong-gu
Daejeon 34071 / KR
03 / KIM, Jae Hak
108-904
136 Doanbuk-ro
Seo-gu
Daejeon 35351 / KR
04 / SHIN, Hong Suk
104-502
31 Songcheon-ro
Deokjin-gu
Jeonju-si Jeollabuk-do 54839 / KR
05 / SON, Jong Chan
158-8 Honggol 1-gil
Chubu-myeon
Geumsan-gun Chungcheongnam-do 32710 / KR
06 / LEE, Chong-Kyo
107-604
43 Gajeong-ro
Yuseong
Daejeon 34118 / KR
07 / KIM, Kyungjin
7F MSA Bldg.
12 Teheran-ro 78-gil
Gangnam-gu
Seoul 06194 / KR
08 / KIM, Uk-il
171 Haean-ro
Danwon-gu
Ansan-si
Gyeonggi-do 15610 / KR
09 / NAM, Hwa Jung
46 Suyeong-ro 636beon-gil
Suyeong-gu
Busan 48270 / KR
 [2020/06]
Representative(s)Michalski Hüttermann & Partner Patentanwälte mbB
Kaistraße 16A
40221 Düsseldorf / DE
[2023/03]
Former [2020/06]Michalski Hüttermann & Partner Patentanwälte mbB
Speditionstraße 21
40221 Düsseldorf / DE
Application number, filing date17901680.324.03.2017
[2020/06]
WO2017KR03194
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018174320
Date:27.09.2018
Language:KO
[2018/39]
Type: A1 Application with search report 
No.:EP3604303
Date:05.02.2020
Language:EN
[2020/06]
Type: B1 Patent specification 
No.:EP3604303
Date:18.01.2023
Language:EN
[2023/03]
Search report(s)International search report - published on:KR27.09.2018
(Supplementary) European search report - dispatched on:EP08.09.2020
ClassificationIPC:C07D471/04, A61K31/437, A61K31/4155, A61P31/18
[2020/41]
CPC:
A61P31/18 (EP,RU,US); C07D471/04 (EP,KR,RU,US); A61K31/4155 (KR);
A61K31/437 (KR,RU)
Former IPC [2020/06]C07D471/04, A61K31/437, A61K31/4155
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/06]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:NEUES PYRROLOPYRIDINDERIVAT, VERFAHREN ZU SEINER HERSTELLUNG UND SEINE VERWENDUNG[2022/34]
English:NOVEL PYRROLOPYRIDINE DERIVATIVE, METHOD FOR PRODUCING SAME, AND USE THEREOF[2020/06]
French:NOUVEAU DÉRIVÉ DE PYRROLOPYRIDINE, SON PROCÉDÉ DE PRODUCTION ET SON UTILISATION[2020/06]
Former [2020/06]NEUES PYRROLOPYRIDINDERIVAT, VERFAHREN ZU SEINER HERSTELLUNG UND VERWENDUNG DAVON
Entry into regional phase23.10.2019Translation filed 
23.10.2019National basic fee paid 
23.10.2019Search fee paid 
23.10.2019Designation fee(s) paid 
23.10.2019Examination fee paid 
Examination procedure23.10.2019Examination requested  [2020/06]
24.03.2021Amendment by applicant (claims and/or description)
12.08.2022Communication of intention to grant the patent
08.12.2022Fee for grant paid
08.12.2022Fee for publishing/printing paid
08.12.2022Receipt of the translation of the claim(s)
Opposition(s)19.10.2023No opposition filed within time limit [2023/52]
Fees paidRenewal fee
23.10.2019Renewal fee patent year 03
18.03.2020Renewal fee patent year 04
30.03.2021Renewal fee patent year 05
16.03.2022Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipEE18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
MC18.01.2023
RO18.01.2023
RS18.01.2023
SI18.01.2023
SK18.01.2023
SM18.01.2023
LU24.03.2023
GR19.04.2023
IS18.05.2023
[2024/11]
Former [2024/02]EE18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
MC18.01.2023
RO18.01.2023
RS18.01.2023
SK18.01.2023
SM18.01.2023
LU24.03.2023
GR19.04.2023
IS18.05.2023
Former [2023/50]EE18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
MC18.01.2023
RO18.01.2023
RS18.01.2023
SK18.01.2023
SM18.01.2023
GR19.04.2023
IS18.05.2023
Former [2023/49]EE18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
MC18.01.2023
RO18.01.2023
RS18.01.2023
SM18.01.2023
GR19.04.2023
IS18.05.2023
Former [2023/48]EE18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
MC18.01.2023
RS18.01.2023
SM18.01.2023
GR19.04.2023
IS18.05.2023
Former [2023/46]FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
RS18.01.2023
SM18.01.2023
GR19.04.2023
IS18.05.2023
Former [2023/39]FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
RS18.01.2023
GR19.04.2023
IS18.05.2023
Former [2023/37]FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
RS18.01.2023
GR19.04.2023
Former [2023/36]FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
RS18.01.2023
Former [2023/35]HR18.01.2023
LT18.01.2023
RS18.01.2023
Former [2023/34]LT18.01.2023
RS18.01.2023
Former [2023/33]LT18.01.2023
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[A]WO2005103003  (PFIZER [US], et al)[A] 1-7;
 [X]WO2013012649  (GLAXOSMITHKLINE LLC [US], et al) [X] 1-7;
 [A]WO2014009794  (VIIV HEALTHCARE UK LTD [GB]) [A] 1-7;
 [X]US2014249162  (SON JONG CHAN [KR], et al) [X] 1-7;
 [X]KR20150141275  (KOREA RES INST CHEM TECH [KR], et al) [X] 1-7
by applicantWO2010132999
 WO2013073875
    - FRAUKE CHRISTZEGER DEBYSER et al., Nature Chemical Biology, (20100000), vol. 6, page 442
    - FREY, R. R, J. Med. Chem., (20080000), vol. 51, pages 3777 - 3787
    - H. TANAKA et al., J. Med. Chem., (19910000), vol. 34, page 349
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.